Science Explorer Interactive view Map
Nonprofit · Tokyo · Japan

Japan Cancer Society

In research, Japan Cancer Society stands highest in Medicine (#15,393 of 17,978 worldwide) and Health Sciences (#18,196 of 20,462 worldwide), over all time. Relative to its size it is most specialised in Medicine and Health Sciences — Medicine is 3.4× its share of world research.

jcancer.jp/enROR OpenAlex
World rank, all time
#34,162
of 42,892
Rank in Japan
#1,454
of 2,112
Research works
233
▲ 29% vs 2013–17
Citations
5.1k
21.9 per fractional work
Top-10% rate
10.4%
record average 16.5%
Open access
50%
world 28%

What is Japan Cancer Society known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #15,393 of 17,978 12.9%153
Health SciencesDomain #18,196 of 20,462 12.9%161

Each strip is that field’s whole ranked pool, with the notch where Japan Cancer Society sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

What does Japan Cancer Society specialise in?

Where its research is concentrated relative to its size: Medicine takes 3.4× the share of its output that it takes of world research.

  1. MedicineField · 25.7 works3.4×
  2. Health SciencesDomain · 26.7 works3.0×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.06× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.30× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 0.82× its world share, 0 worksImmunology and Micro…Neuroscience: 0.96× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.64× its world share, 0 worksPharmacology, Toxico…Chemical Engineering: 0.82× its world share, 0 worksChemical EngineeringChemistry: 0.55× its world share, 0 worksChemistryComputer Science: 0.15× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.55× its world share, 0 worksEarth and Planetary …Engineering: 0.13× its world share, 1 worksEngineeringEnvironmental Science: 0.42× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.12× its world share, 0 worksMaterials ScienceMathematics: 0.36× its world share, 0 worksMathematicsPhysics and Astronomy: 0.77× its world share, 1 worksPhysics and AstronomyDentistry: 0.60× its world share, 0 worksDentistryHealth Professions: 0.79× its world share, 1 worksHealth ProfessionsMedicine: 3.43× its world share, 26 worksMedicineNursing: 0.87× its world share, 0 worksNursingEconomics, Econometrics and Finance: 0.03× its world share, 0 worksEconomics, Econometr…Psychology: 0.78× its world share, 1 worksPsychologySocial Sciences: 0.24× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 3.6×. Every wedge is a field page.

Which keywords describe research at Japan Cancer Society?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Radiotherapy, Tumor Microenvironment, Clinical Practice Guidelines, Clinical Trials, Gastric Cancer, Prevention and Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy6▲ 21×16 topics
  2. Radiotherapy4▲ 29×9 topics
  3. Inflammation3▲ 3.5×15 topics
  4. Epidemiology2▲ 1.63×20 topics
  5. Tumor Microenvironment2▲ 14×5 topics
  6. Clinical Practice Guidelines2▲ 11×9 topics
  7. Clinical Trials2▲ 8.3×7 topics
  8. Gastric Cancer2▲ 48×3 topics
  9. Immunotherapy2▲ 7.6×11 topics
  10. Prevention2▲ 13×5 topics
  11. Adjuvant Therapy2▲ 40×2 topics
  12. Tumor Hypoxia2▲ 77×2 topics
  13. Human Papillomavirus2▲ 40×2 topics
  14. Survival2▲ 37×3 topics
  15. HIF-12▲ 78×1 topic
  16. Warburg Effect2▲ 78×1 topic
  17. Lung Cancer2▲ 26×2 topics
  18. Pathogenesis2▲ 8.7×4 topics
  19. Targeted Therapy2▲ 20×3 topics
  20. Breast Cancer2▲ 17×10 topics
  21. Cetuximab2▲ 50×2 topics
  22. Prognosis2▲ 13×3 topics
  23. Prognostic Factors2▲ 9.4×10 topics
  24. Antibiotic Resistance2▲ 9.9×1 topic
  25. CT Screening2▲ 59×1 topic
  26. Helicobacter pylori2▲ 113×1 topic
  27. Oropharyngeal Cancer2▲ 74×1 topic
  28. Squamous Cell Carcinoma2▲ 43×1 topic
  29. Tumor Staging2▲ 36×1 topic
  30. Biomarkers1▲ 4.7×6 topics
  31. Metastasis1▲ 9.4×6 topics
  32. Survival Analysis1▲ 12×5 topics
  33. Genomic Profiling1▲ 30×2 topics
  34. Neoadjuvant Therapy1▲ 13×4 topics
  35. Radiation Therapy1▲ 24×4 topics
  36. ALK Inhibitors1▲ 46×1 topic
  37. Cancer Incidence1▲ 21×3 topics
  38. EGFR Mutations1▲ 46×1 topic
  39. Molecular Classification1▲ 19×3 topics
  40. Treatment Guidelines1▲ 14×2 topics

Which research topics does Japan Cancer Society publish most on?

By volume in 2022–2025: Cancer, Hypoxia, and Metabolism, Head and Neck Cancer Studies, Helicobacter pylori-related gastroenterology studies and Lung Cancer Diagnosis and Treatment.

Cancer, Hypoxia, and Metabolism: 2 fractional worksHead and Neck Cancer Studies: 2 fractional worksHelicobacter pylori-rela…2Helicobacter pylori-related gastroenterology studies: 2 fractional worksLung Cancer Diagnosis an…2Lung Cancer Diagnosis and Treatment: 2 fractional worksLung Cancer Treatments a…1Lung Cancer Treatments and Mutations: 1 fractional worksLandslides and related h…1Landslides and related hazards: 1 fractional worksOccupational and environ…1Occupational and environmental lung diseases: 1 fractional worksGlobal Cancer Incidence and Screening: 1 fractional worksPleural and Pulmonary Diseases: 0 fractional worksEsophageal Cancer Research and Treatment: 0 fractional works
Cancer ResearchOtorhinolaryngologySurgeryPulmonary and Respiratory Medicine2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer, Hypoxia, and Metabolism Cancer Research 2 works
  2. 2 Head and Neck Cancer Studies Otorhinolaryngology 2 works
  3. 3 Helicobacter pylori-related gastroenterology studies Surgery 2 works
  4. 4 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 2 works
  5. 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  6. 6 Landslides and related hazards Management, Monitoring, Policy and Law 1 works
  7. 7 Occupational and environmental lung diseases Pulmonary and Respiratory Medicine 1 works
  8. 8 Global Cancer Incidence and Screening Oncology 1 works
  9. 9 Pleural and Pulmonary Diseases Pulmonary and Respiratory Medicine 0 works
  10. 10 Esophageal Cancer Research and Treatment Surgery 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available50.4%not open49.6%

World: 28% of research is openly available.

with international co-authors16.4%domestic only83.6%

World: 19% is written across borders.

How has Japan Cancer Society's research output changed?

Output in 2018–2022 was 29% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tokyo

All research institutions in Tokyo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.